93 drugs marketed in France would be dangerous, according to a medical journal

Not necessarily future Mediators (…) if the health actors react in time
– “Prescrivi” review

Among the new bans is Propecia, a widely used drug against hair loss in men. The Medicines Agency (ANSM) had already warned of the psychiatric (anxiety, depression) and sexual (ejaculation disorders, decreased libido) risks that this anti-baldness treatment could cause. Another drug not recommended is Nootropyl, a treatment used against cognitive disorders related to aging.

Finally, a dozen drugs of the gliflozin family, against diabetes, are also among the drugs to be excluded. The drugs on this list are “causes of death, hospitalization or serious or very troublesome adverse effects, largely avoidable”, according to the review To prescribe. These are however “not necessarily a future Mediator, at the center of scandals and lawsuits (…) Especially if all health professionals react in time “.